The U.S. Food and Drug Administration (FDA) has classified a recall of Insulet Corporation's (NASDAQ:PODD) Omnipod 5 Pods as its most serious type, warning that continued use of affected devices could result in severe injury or death.

FDA Labels Omnipod 5 Recall As Most Serious

The recall involves removing certain devices from use due to a defect that may compromise insulin delivery.

The agency's designation underscores concerns that patients relying on the device for diabetes management may face significant health risks if impacted units are not promptly discontinued.

Read Also:

Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves

Injury Reports And Device Use

The company reported 476 serious injuries associated with the issue, though no deaths have been recorded.

The ...